Hospital
Auburn Community Hospital
Auburn Community Hospital was paid $26.18M by Medicaid between Jan 2018 and Dec 2024, across 257 billing codes. Its largest line is 99285, emergency room visit (most serious) — 8.1% of everything it billed.
33Billing provider infoAUBURN COMMUNITY HOSPITAL
AUBURN, NY 13021
AUBURN, NY 13021
33aNPI1093712911assigned 07/07/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$26.18M
24GClaims768,179
24DCodes billed257
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#49 of 231
Median peer was paid$561K
This provider vs. median47×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,716 | $6K | |
| 2019 | 103,086 | $2.57M | |
| 2020 | 111,108 | $2.91M | |
| 2021 | 143,911 | $4.13M | |
| 2022 | 148,019 | $6.79M | |
| 2023 | 147,018 | $5.65M | |
| 2024incomplete | 113,321 | $4.14M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.1% | 15,521 | 14,378 | $2.13M |
| 36415 | Collection of venous blood by venipuncture | 7.8% | 100,254 | 31,842 | $2.05M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.4% | 11,164 | 10,665 | $1.94M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.4% | 14,574 | 13,839 | $1.68M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.2% | 10,700 | 10,225 | $1.61M |
| 96361 | Intravenous infusion, hydration; each additional hour | 5.4% | 6,549 | 6,133 | $1.41M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.6% | 10,586 | 9,965 | $1.22M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.8% | 3,561 | 3,485 | $1000K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3.4% | 1,084 | 1,083 | $880K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 3.1% | 710 | 705 | $812K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.1% | 2,583 | 2,543 | $809K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.8% | 9,023 | 2,823 | $739K |
245 more codes
| 80053 | Comprehensive metabolic panel | 2.7% | 40,659 | $720K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.1% | 6,776 | $561K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.1% | 2,794 | $544K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.1% | 3,693 | $541K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.6% | 3,315 | $426K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 5,336 | $368K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.3% | 1,262 | $337K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.2% | 2,126 | $310K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.2% | 3,244 | $306K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 14,936 | $295K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 5,672 | $223K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 995 | $201K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,158 | $179K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 7,790 | $176K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,236 | $166K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 5,433 | $164K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 7,790 | $161K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,350 | $160K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 509 | $157K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 787 | $148K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 7,597 | $144K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 5,271 | $142K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 18,127 | $137K |
| 45384 | <1% | 92 | $110K | |
| 88142 | <1% | 4,889 | $105K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,693 | $97K |
| 81025 | <1% | 3,357 | $95K | |
| 80061 | Lipid panel | <1% | 15,013 | $95K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,163 | $90K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 580 | $89K |
| 87070 | <1% | 14,480 | $87K | |
| 97016 | <1% | 4,393 | $80K | |
| 83880 | <1% | 2,427 | $77K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 38,175 | $75K |
| 12001 | <1% | 160 | $75K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,796 | $72K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,058 | $70K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14,380 | $68K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,005 | $63K |
| 87481 | <1% | 2,142 | $61K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 3,446 | $60K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 191 | $57K |
| 82607 | <1% | 4,756 | $56K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,365 | $56K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,601 | $54K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,389 | $53K |
| 97161 | <1% | 543 | $50K | |
| 84439 | <1% | 5,873 | $48K | |
| 86850 | <1% | 3,418 | $47K | |
| 82746 | <1% | 3,967 | $46K | |
| 94060 | <1% | 432 | $46K | |
| 86780 | <1% | 3,543 | $42K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,341 | $40K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,287 | $39K |
| 86900 | <1% | 3,482 | $37K | |
| 86901 | <1% | 3,384 | $36K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 295 | $34K |
| 97010 | <1% | 1,839 | $34K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,152 | $33K |
| 84153 | <1% | 1,656 | $31K | |
| 82728 | <1% | 2,417 | $30K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,450 | $28K |
| 76770 | <1% | 333 | $26K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 90 | $26K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,798 | $25K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 82 | $25K |
| G0378 | Hospital observation service, per hour | <1% | 453 | $24K |
| 85027 | <1% | 8,592 | $23K | |
| 87077 | <1% | 3,692 | $23K | |
| 93971 | <1% | 337 | $23K | |
| 97162 | <1% | 176 | $22K | |
| 84702 | <1% | 2,699 | $22K | |
| 87340 | <1% | 2,263 | $22K | |
| 86803 | <1% | 2,357 | $21K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 30 | $21K |
| 83540 | <1% | 4,334 | $20K | |
| 76830 | Ultrasound, transvaginal | <1% | 378 | $20K |
| 94726 | <1% | 199 | $19K | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | <1% | 491 | $18K |
| 88312 | <1% | 831 | $18K | |
| 87088 | <1% | 3,283 | $17K | |
| 97014 | <1% | 1,208 | $17K | |
| 84480 | <1% | 3,685 | $17K | |
| 88304 | <1% | 592 | $17K | |
| 83550 | <1% | 3,652 | $17K | |
| 87184 | <1% | 3,923 | $16K | |
| 84146 | <1% | 825 | $16K | |
| 80076 | <1% | 2,206 | $16K | |
| 86141 | <1% | 2,487 | $14K | |
| 84436 | <1% | 4,304 | $14K | |
| 51741 | <1% | 16 | $13K | |
| 83970 | <1% | 353 | $13K | |
| 83735 | <1% | 8,049 | $13K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,439 | $13K |
| 82803 | <1% | 559 | $13K | |
| 83655 | <1% | 980 | $13K | |
| 81001 | <1% | 10,249 | $13K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 208 | $12K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,096 | $12K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 70 | $11K |
| 93017 | <1% | 137 | $9K | |
| 70486 | <1% | 126 | $9K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 479 | $9K |
| 76641 | <1% | 357 | $8K | |
| 71250 | <1% | 93 | $8K | |
| 90715 | <1% | 315 | $8K | |
| 85610 | <1% | 9,739 | $8K | |
| 59025 | Fetal non-stress test | <1% | 127 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,798 | $7K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 50 | $6K |
| 85651 | <1% | 3,711 | $6K | |
| 82043 | <1% | 1,129 | $5K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 16 | $5K |
| 85730 | <1% | 8,031 | $5K | |
| 82950 | <1% | 960 | $5K | |
| 84550 | <1% | 1,309 | $5K | |
| 86038 | <1% | 956 | $5K | |
| 84481 | <1% | 551 | $5K | |
| 94729 | <1% | 232 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 253 | $5K |
| 71271 | <1% | 209 | $4K | |
| 73564 | <1% | 960 | $4K | |
| 83690 | <1% | 6,418 | $4K | |
| 87081 | <1% | 862 | $4K | |
| 83001 | <1% | 233 | $4K | |
| 72110 | <1% | 468 | $4K | |
| 76536 | <1% | 195 | $4K | |
| 74018 | <1% | 854 | $4K | |
| 77066 | Tomosynthesis, mammo | <1% | 67 | $4K |
| 87634 | <1% | 655 | $4K | |
| 86705 | <1% | 447 | $4K | |
| 87205 | <1% | 2,118 | $4K | |
| 73030 | <1% | 851 | $4K | |
| 96367 | <1% | 113 | $4K | |
| 86709 | <1% | 424 | $4K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 1,231 | $4K |
| 82150 | <1% | 5,243 | $4K | |
| 86430 | <1% | 738 | $3K | |
| 51798 | <1% | 12 | $3K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,079 | $3K |
| 72141 | <1% | 14 | $3K | |
| 73630 | <1% | 1,266 | $3K | |
| 83002 | <1% | 176 | $3K | |
| 76857 | <1% | 216 | $3K | |
| 81003 | <1% | 4,302 | $3K | |
| 93225 | <1% | 25 | $3K | |
| 84100 | <1% | 735 | $3K | |
| 82550 | <1% | 4,839 | $3K | |
| 87807 | <1% | 289 | $3K | |
| 87430 | <1% | 2,800 | $3K | |
| 80074 | <1% | 51 | $2K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 2,252 | $2K |
| 76801 | <1% | 28 | $2K | |
| 86376 | <1% | 172 | $2K | |
| 85007 | <1% | 2,588 | $2K | |
| 84484 | <1% | 6,689 | $2K | |
| 86140 | <1% | 979 | $2K | |
| 86618 | <1% | 149 | $2K | |
| 73130 | <1% | 911 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 14 | $2K |
| 81002 | <1% | 3,349 | $2K | |
| 93226 | <1% | 16 | $2K | |
| 82248 | <1% | 419 | $2K | |
| 84703 | <1% | 3,639 | $2K | |
| 73610 | <1% | 1,111 | $2K | |
| 81015 | <1% | 907 | $2K | |
| 82570 | <1% | 349 | $2K | |
| 87802 | <1% | 1,063 | $1K | |
| 82948 | <1% | 3,292 | $1K | |
| 85379 | <1% | 1,385 | $1K | |
| 87040 | <1% | 2,438 | $1K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 189 | $1K |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 82 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 92 | $987.42 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 5,134 | $978.81 |
| 84156 | <1% | 266 | $855.91 | |
| 73110 | <1% | 406 | $824.37 | |
| 83525 | <1% | 68 | $784.40 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,393 | $706.98 |
| 95816 | <1% | 14 | $650.85 | |
| 86800 | <1% | 51 | $645.45 | |
| 82627 | <1% | 29 | $627.16 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 358 | $533.07 |
| 84134 | <1% | 65 | $499.43 | |
| 73502 | <1% | 96 | $491.09 | |
| 82533 | <1% | 26 | $456.84 | |
| 93000 | <1% | 41 | $366.91 | |
| 86706 | <1% | 43 | $357.08 | |
| 87660 | <1% | 27 | $348.25 | |
| 87510 | <1% | 27 | $348.25 | |
| 87480 | <1% | 27 | $348.25 | |
| 82670 | <1% | 12 | $333.88 | |
| 83605 | <1% | 1,807 | $305.89 | |
| 80143 | <1% | 857 | $302.02 | |
| 76642 | <1% | 13 | $293.44 | |
| 86769 | <1% | 13 | $283.38 | |
| 72100 | <1% | 14 | $257.55 | |
| 96368 | <1% | 20 | $242.48 | |
| 82077 | <1% | 1,577 | $205.34 | |
| 80179 | <1% | 799 | $204.31 | |
| 74019 | <1% | 25 | $190.76 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 8,059 | $167.91 |
| 86308 | <1% | 79 | $163.96 | |
| 82140 | <1% | 27 | $145.94 | |
| 80320 | <1% | 1,048 | $126.63 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,405 | $125.12 |
| 82947 | <1% | 26 | $102.78 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 504 | $67.57 |
| 72050 | <1% | 13 | $60.60 | |
| 82977 | <1% | 13 | $58.39 | |
| 96376 | <1% | 259 | $43.21 | |
| 80335 | <1% | 1,048 | $42.44 | |
| 83615 | <1% | 14 | $39.55 | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,941 | $38.22 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,769 | $37.63 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,460 | $36.51 |
| 85014 | <1% | 14 | $35.91 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,740 | $35.67 |
| 84145 | <1% | 391 | $31.30 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,869 | $28.66 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 53 | $25.26 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 651 | $24.93 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 381 | $16.44 |
| 73080 | <1% | 29 | $15.00 | |
| 71101 | <1% | 25 | $11.03 | |
| 80329 | <1% | 1,242 | $10.75 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 118 | $8.36 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,438 | $6.94 |
| 73590 | <1% | 12 | $6.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 15 | $5.20 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 648 | $5.17 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,391 | $5.06 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 393 | $1.68 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 431 | $0.01 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 88 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 12 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 455 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 116 | $0.00 |
| 0011A | 0% | 17 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 28 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 206 | $0.00 |
| 0012A | 0% | 17 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 14 | $0.00 |
| C1726 | Catheter, balloon dilatation, non-vascular | 0% | 14 | $0.00 |
| 73090 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLESCH, JASON (CFO)
| Provider | Location | Paid |
|---|---|---|
| Auburn Community Hospital | Auburn, NY | $32K |
| Auburn Community Hospital | Auburn, NY | $11K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.